TERT and cutaneous melanoma: Intriguingly, mutations in the human TERT (Telomerase Reverse Transcriptase) promoter have been found in benign skin nevi, arguing against a role of these well-known mutations in cancer progression, and suggesting that further analysis is required before extending the use of this mutation as a biomarker for cutaneous melanoma.9